Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial

Faster, Cleaner, Better.

GT Biopharma Inc (GTBP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2020	12-2019	12-2018	12-2017	12-2016
Assets
Current Assets
Cash & Cash Equivalents	5,297	28	60	576	19
TOTAL	$5,661	$274	$90	$576	$21

Non-Current Assets
PPE Net	N/A	N/A	35	6	4
Intangibles	0	0	25,262	253,777	0
Other Non-Current Assets	0	122	12	9	0
TOTAL	$N/A	$122	$25,309	$253,792	$4

Total Assets	$5,661	$396	$25,399	$254,368	$25

Liabilities
Current Liabilities
Short Term Debt	26,303	13,207	10,673	0	11,239
Accounts payable and accrued liabilities	2,243	1,940	1,762	2,546	2,100
Accrued Expenses	6,134	4,408	1,455	102	4,019
Other current liabilities	383	N/A	N/A	N/A	417
TOTAL	$35,094	$19,706	$14,029	$2,679	$18,949

Non-Current Liabilities
Deferred Revenues	N/A	N/A	8	N/A	N/A
TOTAL	$N/A	$N/A	$N/A	$N/A	$N/A

Total Liabilities	$35,094	$19,706	$14,029	$2,679	$18,949

Shareholders' Equity
Shares Outstanding, K	946	138	101	98	241
Common Shares	5	41	51	50	0
Retained earnings	-595,797	-567,332	-528,685	-269,499	-124,649
Other shareholders' equity	3	-166	-167	-167	-166
TOTAL	$-29,433	$-19,310	$11,370	$251,689	$-18,924

Total Liabilities And Equity	$5,661	$396	$25,399	$254,368	$25